TI
TNDM icon

Trexquant Investment’s Tandem Diabetes Care TNDM Stock Holding History

Trexquant Investment’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Sell
90,058
-159,240
-64% -$2.78M 0.01% 1356
2026
Q1 		$4.78M Buy
249,298
+146,579
+143% +$3.18M 0.03% 666
2025
Q4 		$2.26M Sell
102,719
-395,001
-79% -$7.13M 0.02% 951
2025
Q3 		$6.04M Buy
497,720
+129,190
+35% +$1.75M 0.06% 476
2025
Q2 		$6.87M Buy
+368,530
New +$7.3M 0.08% 404
2025
Q1 		– Sell
-211,206
Closed -$7.61M – 1875
2024
Q4 		$7.61M Buy
211,206
+73,838
+54% +$2.5M 0.09% 367
2024
Q3 		$5.83M Sell
137,368
-71,021
-34% -$3.01M 0.07% 416
2024
Q2 		$8.4M Sell
208,389
-24,694
-11% -$1.03M 0.13% 241
2024
Q1 		$8.25M Buy
233,083
+71,129
+44% +$1.91M 0.16% 165
2023
Q4 		$4.79M Buy
161,954
+99,631
+160% +$2.07M 0.11% 266
2023
Q3 		$1.29M Buy
+62,323
New +$1.71M 0.03% 651
2022
Q2 		– Sell
-26,225
Closed -$3.05M – 1868
2022
Q1 		$3.05M Buy
26,225
+7,177
+38% +$838K 0.14% 179
2021
Q4 		$2.87M Buy
19,048
+14,908
+360% +$2.01M 0.18% 137
2021
Q3 		$494K Sell
4,140
-4,548
-52% -$501K 0.04% 544
2021
Q2 		$846K Sell
8,688
-6,851
-44% -$611K 0.07% 345
2021
Q1 		$1.37M Buy
15,539
+12,449
+403% +$1.16M 0.13% 212
2020
Q4 		$296K Sell
3,090
-14,826
-83% -$1.53M 0.03% 695
2020
Q3 		$2.03M Buy
17,916
+14,033
+361% +$1.47M 0.13% 214
2020
Q2 		$384K Buy
+3,883
New +$310K 0.03% 776
2018
Q3 		– Sell
-47,133
Closed -$1.04M – 1196
2018
Q2 		$1.04M Buy
+47,133
New +$580K 0.07% 365

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Trexquant Investment's TNDM Position: Q2 2026 in Review

Trexquant Investment reduced its Tandem Diabetes Care (TNDM) stake by 64% in Q2 2026, selling an estimated $2.78M and leaving 90,058 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #1356.

Trexquant Investment first reported a position in TNDM in Q2 2018 and has held it in 20 quarters since. The position peaked at $8.4M in Q2 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Trexquant Investment held 90,058 shares of Tandem Diabetes Care worth $1.36M as of Q2 2026.
  • Trexquant Investment sold 159,240 Tandem Diabetes Care shares in Q2 2026, an estimated $2.78M.
  • Tandem Diabetes Care made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1356 holding.
  • Trexquant Investment first reported a position in Tandem Diabetes Care in Q2 2018 and has held it in 20 quarters since.
  • Trexquant Investment's Tandem Diabetes Care position peaked at $8.4M in Q2 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.